Blog Posts by Date: Apr 2021


Preparing for Market Disruption – Operational Lessons From COVID-19

Conor WardVP of Sales, XIFIN Joe NollarAVP LIS Product Development, XIFIN In March 2021, we had the privilege of being interviewed by Linda Wilson, Senior Editor of Medical Laboratory Observer (MLO). The discussion focused on...

Read



UHC Implements DEX Z-Code Requirements on Medicare Advantage Claims Starting June 1, 2021

Effective 6/1/2021, UHC will require pathology providers currently submitting a DEX Z-Code for the Medicare MolDx program to also submit their registered Z-code on UHC Medicare Advantage claims. In the same format as Medicare, the Z-code will be submitted in Loop 2400. While UHC will not require a separate registration of these z-codes, providers...

Read



The Remaining 20%: How Payor Policies and Specific Language Increase Success Rates of Appeals (Part 3)

This blog post is part three of the series. View part one. View part two. As we’ve covered statistically where our greatest challenges and opportunities lie, it’s important to recognize the appeal process is NOT a one-size-fits-all solution. Lesson 1: Report Documentation — “If it isn’t...

Read



After Large Spikes in 2020, Diagnostic Laboratory Testing Volumes on the Decline

As XIFIN CEO Lâle White wrote in her recent LinkedIn article, the COVID-19 pandemic created many challenges for the diagnostic industry in 2020. In the preceding years, many laboratories were running lean with little excess capacity. With the surge in COVID-19 testing demand, labs had to quickly add capacity to handle the new testing volume...

Read